KR920701154A - 비시클로락탐 유도체 - Google Patents

비시클로락탐 유도체

Info

Publication number
KR920701154A
KR920701154A KR1019910701243A KR910701243A KR920701154A KR 920701154 A KR920701154 A KR 920701154A KR 1019910701243 A KR1019910701243 A KR 1019910701243A KR 910701243 A KR910701243 A KR 910701243A KR 920701154 A KR920701154 A KR 920701154A
Authority
KR
South Korea
Prior art keywords
group
bicyclolactam
lower alkoxy
substituent
derivative according
Prior art date
Application number
KR1019910701243A
Other languages
English (en)
Other versions
KR940004059B1 (ko
Inventor
아끼히로 가와구찌
아쓰시 사또오
마꼬도 가지다니
미쓰기 야스모도
쥰지 야마모도
Original Assignee
고바야시 유끼오
다이호오 야꾸힌 고오교오 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고바야시 유끼오, 다이호오 야꾸힌 고오교오 가부시끼가이샤 filed Critical 고바야시 유끼오
Publication of KR920701154A publication Critical patent/KR920701154A/ko
Application granted granted Critical
Publication of KR940004059B1 publication Critical patent/KR940004059B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

내용 없음

Description

비시클로락탐 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 일반식
    (식중, R는 치환기로서 할로겐 원자, 저급알킬기, 저급알콕시기, 니트로기, 시아노기 또는 아미노기를 가지고 있어도 좋은 벤조일기를 표시한다. ℓ는 1또는 2를 m은 0또는 1을, n은 0,1 또는 2를 표시한다. 단, m,n이 동시에 0인 경우는 제외된다.)으로 나타내는 비시클로락탐유도체.
  2. 제1항에 있어서, R은 치환기로서 저급알콕시기 또는 아미노기를 가지는 벤조일기이고, ℓ은 1또는 2, m은 0또는 1, n은 0또는 2인 것을 특징으로 하는 비시클로락탐유도체.
  3. 제1항에 있어서, R은 치환기로서 저급 알콕시기를 가지는 벤조일기이며, ℓ은 1, m은 0, n은 2인 것을 특징으로 하는 비시클로락탐유도체.
  4. 제1항에 있어서, R은 치환기로서 저급 알콕시기를 가지는 벤조일기이며, ℓ은 2, m은 1, n은 0인 것을 특징으로 하는 비시클로락탐유도체.
  5. 제1항 기재의 비시클로락탐유도체의 유효량과 약리학적으로 허용되는 담체를 함유하는 뇌기능 개선 및 뇌대사 부활 보호제.
  6. 제1항 기재의 비시클로락탐유도에 유효량을 환자에게 투여하는 것을 특징으로 하는 뇌기능 개선 및 뇌대사 부활 보호방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910701243A 1990-02-02 1991-01-30 비시클로락탐유도체 KR940004059B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2475490 1990-02-02
JP90-24754 1990-02-02
PCT/JP1991/000116 WO1991011434A1 (fr) 1990-02-02 1991-01-30 Derive de bicyclolactame

Publications (2)

Publication Number Publication Date
KR920701154A true KR920701154A (ko) 1992-08-11
KR940004059B1 KR940004059B1 (ko) 1994-05-11

Family

ID=12146933

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910701243A KR940004059B1 (ko) 1990-02-02 1991-01-30 비시클로락탐유도체

Country Status (13)

Country Link
US (1) US5185344A (ko)
EP (2) EP0668268A3 (ko)
JP (1) JP2676170B2 (ko)
KR (1) KR940004059B1 (ko)
AT (1) ATE130605T1 (ko)
AU (1) AU627399B2 (ko)
CA (1) CA2050587C (ko)
DE (1) DE69114778T2 (ko)
DK (1) DK0466933T3 (ko)
ES (1) ES2083568T3 (ko)
GR (1) GR3018235T3 (ko)
HU (1) HU211635A9 (ko)
WO (1) WO1991011434A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159987A (en) * 1994-03-28 2000-12-12 Taiho Pharmaceuticals, Co. Bicyclolactam compounds, use thereof and intermediates for preparing thereof
CA2163216C (en) * 1994-03-28 1999-08-31 Junji Yamamoto Anxiolytic agent
JP3161948B2 (ja) * 1995-06-12 2001-04-25 大鵬薬品工業株式会社 ビシクロラクタム化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619937A (en) * 1984-02-02 1986-10-28 Warner-Lambert Company Saturated bicyclic lactam acids and derivatives as cognition activators
US4758585A (en) * 1985-08-16 1988-07-19 Warner-Lambert Company Saturated cycloalkyl (B) pyrrol-1 (2H)- acetic acid amides and derivatives thereof
US4621097A (en) * 1985-08-16 1986-11-04 Warner-Lambert Company Saturated cycloalkyl[c] pyrrole-2(1H)-acetic acid amides and derivatives thereof

Also Published As

Publication number Publication date
EP0466933A1 (en) 1992-01-22
US5185344A (en) 1993-02-09
DE69114778T2 (de) 1996-04-18
GR3018235T3 (en) 1996-02-29
EP0668268A2 (en) 1995-08-23
EP0466933B1 (en) 1995-11-22
DK0466933T3 (da) 1996-01-02
EP0668268A3 (en) 1995-08-30
AU627399B2 (en) 1992-08-20
ATE130605T1 (de) 1995-12-15
ES2083568T3 (es) 1996-04-16
AU7186691A (en) 1991-08-21
CA2050587C (en) 1997-11-25
KR940004059B1 (ko) 1994-05-11
CA2050587A1 (en) 1991-08-03
HU211635A9 (en) 1995-12-28
DE69114778D1 (de) 1996-01-04
JP2676170B2 (ja) 1997-11-12
EP0466933A4 (en) 1992-07-08
WO1991011434A1 (fr) 1991-08-08

Similar Documents

Publication Publication Date Title
RU2221781C2 (ru) Тиолсульфоновые соединения в качестве ингибитора матриксной металлопротеазы и способы лечения
KR920701153A (ko) 옥시인돌 유도체
TW385309B (en) Novel thiazolidinedione antidiabetic agents
FI911443A (fi) Foerfarande foer framstaellning av 3,5-di-tert.butyl-4-hydroxifenylmetylenderivat av 2-substituerade tiazolidinoner, oxazolidinoner och imidazolidinoner med antiinflammatorisk aktivitet.
KR950010888A (ko) 평활근세포 증식 및 재발협착증을 억제하는 방법
KR890011884A (ko) 캠프토데신 유도체
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
KR910014119A (ko) 항-고혈압 활성을 갖는 티아졸리딘 유도체 및 그의 치료용도
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
KR920701154A (ko) 비시클로락탐 유도체
KR900001673A (ko) N-치환 아미드 유도체
DE69232143D1 (de) Verwendung von Amlexanox zur Herstellung eines Arzneimittels zur Behandlung von aphtösen Ulcera
NO900732L (no) Arylalkylaminforbindelser.
DE69222076D1 (de) Benzothiazolederivate
KR910700252A (ko) 디아자비시클로알칸 유도체
ES8505653A1 (es) Procedimiento para preparar un n-alquil-(3 o 4)piperidinil benzoato
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
KR950017967A (ko) 피리다지논 유도체, 그의 제조법 및 그의 용도

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050422

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee